Unknown

Dataset Information

0

Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration.


ABSTRACT: The goal of this study was to investigate the potential for a cannabidiol-rich cannabis extract (CRCE) to interact with the most common over-the-counter drug and the major known cause of drug-induced liver injury-acetaminophen (APAP)-in aged female CD-1 mice. Gavaging mice with 116 mg/kg of cannabidiol (CBD) [mouse equivalent dose (MED) of 10 mg/kg of CBD] in CRCE delivered with sesame oil for three consecutive days followed by intraperitoneally (i.p.) acetaminophen (APAP) administration (400 mg/kg) on day 4 resulted in overt toxicity with 37.5% mortality. No mortality was observed in mice treated with 290 mg/kg of CBD+APAP (MED of 25 mg/kg of CBD) or APAP alone. Following CRCE/APAP co-administration, microscopic examination revealed a sinusoidal obstruction syndrome-like liver injury-the severity of which correlated with the degree of alterations in physiological and clinical biochemistry end points. Mechanistically, glutathione depletion and oxidative stress were observed between the APAP-only and co-administration groups, but co-administration resulted in much greater activation of c-Jun N-terminal kinase (JNK). Strikingly, these effects were not observed in mice gavaged with 290 mg/kg CBD in CRCE followed by APAP administration. These findings highlight the potential for CBD/drug interactions, and reveal an interesting paradoxical effect of CBD/APAP-induced hepatotoxicity.

SUBMITTER: Ewing LE 

PROVIDER: S-EPMC6630875 | biostudies-other | 2019 Jun

REPOSITORIES: biostudies-other

altmetric image

Publications

Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration.

Ewing Laura E LE   McGill Mitchell R MR   Yee Eric U EU   Quick Charles M CM   Skinner Charles M CM   Kennon-McGill Stefanie S   Clemens Melissa M   Vazquez Joel H JH   McCullough Sandra S SS   Williams D Keith DK   Kutanzi Kristy R KR   Walker Larry A LA   ElSohly Mahmoud A MA   James Laura P LP   Gurley Bill J BJ   Koturbash Igor I  

Molecules (Basel, Switzerland) 20190617 12


The goal of this study was to investigate the potential for a cannabidiol-rich cannabis extract (CRCE) to interact with the most common over-the-counter drug and the major known cause of drug-induced liver injury-acetaminophen (APAP)-in aged female CD-1 mice. Gavaging mice with 116 mg/kg of cannabidiol (CBD) [mouse equivalent dose (MED) of 10 mg/kg of CBD] in CRCE delivered with sesame oil for three consecutive days followed by intraperitoneally (i.p.) acetaminophen (APAP) administration (400 mg  ...[more]

Similar Datasets

| S-EPMC6539990 | biostudies-other
| S-EPMC7656295 | biostudies-literature
| S-EPMC7470626 | biostudies-literature
| S-EPMC6515348 | biostudies-literature
| S-EPMC6204085 | biostudies-literature
| S-EPMC8145271 | biostudies-literature
| S-EPMC10051970 | biostudies-literature
| S-EPMC7516211 | biostudies-literature
| S-EPMC2451037 | biostudies-other
| S-EPMC6304886 | biostudies-other